BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 30926417)

  • 1. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Toll like receptors 3 & 7 in peripheral blood from patients with chronic hepatitis C virus infection and their correlation with interferon-alpha.
    Mohammed KI; Adel LA; Ali-Eldin FA; Eladawy S
    Egypt J Immunol; 2013; 20(1):13-22. PubMed ID: 23888553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection.
    Askar E; Ramadori G; Mihm S
    J Med Virol; 2010 Nov; 82(11):1859-68. PubMed ID: 20872712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
    Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
    Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
    El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
    Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.
    Tarantino G; Di Cristina A; Pipitone R; Almasio PL; Di Vita G; Craxi A; Grimaudo S
    J Biol Regul Homeost Agents; 2013; 27(1):233-9. PubMed ID: 23489702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
    Derbala M; Rizk N; Al-Kaabi S; Amer A; Shebl F; Al Marri A; Aigha I; Alyaesi D; Mohamed H; Aman H; Basem N
    J Viral Hepat; 2009 Oct; 16(10):689-96. PubMed ID: 19486470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
    Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic TLR4, MBL and CRP gene expression levels are associated with chronic hepatitis C.
    de Souza Pires-Neto O; da Silva Graça Amoras E; Queiroz MAF; Demachki S; da Silva Conde SR; Ishak R; Cayres-Vallinoto IMV; Vallinoto ACR
    Infect Genet Evol; 2020 Jun; 80():104200. PubMed ID: 31962161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection.
    Aoki Y; Sugiyama M; Murata K; Yoshio S; Kurosaki M; Hashimoto S; Yatsuhashi H; Nomura H; Kang JH; Takeda T; Naito S; Kimura T; Yamagiwa Y; Korenaga M; Imamura M; Masaki N; Izumi N; Kage M; Mizokami M; Kanto T
    J Gastroenterol; 2015 Aug; 50(8):894-902. PubMed ID: 25501286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14
    Zhao SX; Li WC; Fu N; Kong LB; Zhang QS; Han F; Ren WG; Cui P; Du JH; Wang BY; Zhang YG; Wang RQ; Kong L; Nan YM
    Exp Ther Med; 2020 Dec; 20(6):228. PubMed ID: 33149783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.
    Ibrahim MK; Salum GM; Bader El Din NG; Dawood RM; Barakat A; Khairy A; El Awady MK
    PLoS One; 2016; 11(5):e0154512. PubMed ID: 27135246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection.
    Wang X; Wang S; Liu ZH; Qi WQ; Zhang Q; Zhang YG; Sun DR; Xu Y; Wang HG; Li ZX; Cong XL; Zhao P; Zhou CY; Wang JB
    World J Gastroenterol; 2018 May; 24(20):2191-2202. PubMed ID: 29853737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.